Literature DB >> 15062201

Primary sclerosing cholangitis.

Flavia D Mendes1, Keith D Lindor.   

Abstract

Primary sclerosing cholangitis is a cholestatic liver disease strongly associated with IBD. Considerable advances in the understanding of its pathogenesis have been made. The idea of autoimmunity affecting genetically susceptible individuals is largely accepted; however, much remains to be explained about the origin of this disease. Despite active investigation of different therapeutic modalities with the goal of modifying disease progression, liver transplantation continues to be the only option to provide survival benefit in these patients.

Entities:  

Mesh:

Year:  2004        PMID: 15062201     DOI: 10.1016/S1089-3261(03)00127-2

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  10 in total

1.  Current and future therapy for primary sclerosing cholangitis.

Authors:  Flavia Mendes
Journal:  Gastroenterol Hepatol (N Y)       Date:  2008-04

2.  Treatment of Biliary Problems in Inflammatory Bowel Disease.

Authors:  Christopher S Huang; David R Lichtenstein
Journal:  Curr Treat Options Gastroenterol       Date:  2005-04

Review 3.  Approach to a patient with elevated serum alkaline phosphatase.

Authors:  Asma Siddique; Kris V Kowdley
Journal:  Clin Liver Dis       Date:  2012-04-06       Impact factor: 6.126

4.  [Liver transplantation: deciding between need and donor allocation].

Authors:  C P Strassburg; T Becker; J Klempnauer; M P Manns
Journal:  Internist (Berl)       Date:  2004-11       Impact factor: 0.743

Review 5.  Magnetic resonance evaluations of biliary malignancy and condition at high-risk for biliary malignancy: Current status.

Authors:  Reiji Sugita
Journal:  World J Hepatol       Date:  2013-12-27

6.  Indications for non-transplant surgery in primary sclerosing cholangitis.

Authors:  Bastian Domajnko; Steven A Ahrendt
Journal:  HPB (Oxford)       Date:  2005       Impact factor: 3.647

Review 7.  Endoscopy in the management of primary sclerosing cholangitis.

Authors:  Mark McLoughlin; Robert Enns
Journal:  Curr Gastroenterol Rep       Date:  2008-04

Review 8.  Primary sclerosing cholangitis--the arteriosclerosis of the bile duct?

Authors:  Peter Fickert; Tarek Moustafa; Michael Trauner
Journal:  Lipids Health Dis       Date:  2007-01-25       Impact factor: 3.876

Review 9.  Cirrhosis and autoimmune liver disease: Current understanding.

Authors:  Rodrigo Liberal; Charlotte R Grant
Journal:  World J Hepatol       Date:  2016-10-08

10.  Fibroblast Growth Factor 19 Induced Changes in Non-malignant Cholangiocytes.

Authors:  Jiaqi Yang; David Sontag; Sam Kung; Gerald Y Minuk
Journal:  J Clin Transl Hepatol       Date:  2021-06-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.